跳至主要内容
临床试验/NCT02819401
NCT02819401已完成不适用

A Prospective, Open-label, Post-marketing Observational Study to Evaluate the Effects of High-fiber Enteral Pediatric Formula in Children With Failure to Thrive Due to Malnutrition

Abbott Nutrition17 个研究点 分布在 1 个国家目标入组 345 人开始时间: 2013年2月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
345
试验地点
17
主要终点
Physician Perception of Formula Use

研究概览

简要总结

The present study is designed to determine the gastrointestinal tolerability of enteral nutritional products, physicians and parents' overall perception of enteral nutrition products as well as providing basic demographic information on pediatric populations prescribed these formula for supportive treatment as part of the routine healthcare service in Turkey.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
1 Year 至 10 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Age; 1-10 years (inclusive)
  • Children diagnosed as failure-to-thrive(FTT).
  • Children who have been recently prescribed and treatment initiated with isocaloric or hypercaloric high-fiber pediatric enteral formula suitable for oral and/or nasogastric tube feeding before inclusion in the study.

排除标准

  • Chronic renal disorder
  • Decompensated liver disease
  • Any other chronic condition that was not under control (e.g. diabetes, thyroid disorder, etc.)
  • Any type of malignant disease including leukemia and lymphoma
  • Cystic fibrosis
  • Short bowel syndrome
  • Any type of food allergy or intolerance
  • Growth hormone deficiency
  • Use of enteral feeding within the last 4 weeks

结局指标

主要结局

Physician Perception of Formula Use

时间窗: Baseline to Month 6

Questionnaire

次要结局

  • Gastrointestinal Tolerance(Baseline to Month 1, Month 2, Month 4 and Month 6)
  • Description of Population(Baseline)
  • Weight(Baseline to Month 1, Month 2, Month 4 and Month 6)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (17)

Loading locations...

相似试验

The Effects of a High-fiber Formula in Children With... | 临床试验